

[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI
[ Tue, Feb 27th 2024
] - WOPRAI

[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
[ Mon, Feb 26th 2024
] - WOPRAI
Michael Cherny Initiated (XRAY) at Buy and Held Target at $42 on, Feb 26th, 2024
Michael Cherny of Leerink Partners, Initiated "DENTSPLY SIRONA Inc." (XRAY) at Buy and Held Target at $42 on, Feb 26th, 2024.
Michael has made no other calls on XRAY in the last 4 months.
There are 7 other peers that have a rating on XRAY. Out of the 7 peers that are also analyzing XRAY, 3 agree with Michael's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Jason Bednar of "Piper Sandler" Maintained at Hold with Increased Target to $35 on, Friday, January 12th, 2024
- Jonathan Block of "Stifel" Maintained at Hold with Decreased Target to $32 on, Monday, November 13th, 2023
- Nathan Rich of "Goldman Sachs" Maintained at Hold with Decreased Target to $36 on, Tuesday, November 7th, 2023
These are the ratings of the 4 analyists that currently disagree with Michael
- David Saxon of "Needham" Maintained at Strong Buy with Increased Target to $42 on, Tuesday, January 9th, 2024
- Brandon Vazquez of "William Blair" Upgraded from Hold to Buy on, Friday, November 10th, 2023
- Michael Petusky of "Barrington Research" Maintained at Buy with Decreased Target to $41 on, Friday, November 3rd, 2023
- Erin Wright of "Morgan Stanley" Maintained at Buy with Decreased Target to $39 on, Friday, November 3rd, 2023
Contributing Sources